The company said Tuesday it updated the prescribing label of the drug, Librela, to mention rare health problems that had been reported since its introduction in the U.S. in 2023.

Label updates in the pharmaceutical space are not uncommon, particularly in the first few years after a launch in response to real-world experience data. Since its launch in Europe four years ago ...

Gold prices surged by ₹400, reaching a new all-time high of ₹85,300 per 10 grams in the national capital on Monday, driven by sustained demand from jewellers and stockists, according to the ...